Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 20954965)

1.

Review of hepatitis B therapeutics.

Bhattacharya D, Thio CL.

Clin Infect Dis. 2010 Nov 15;51(10):1201-8. doi: 10.1086/656624. Epub 2010 Oct 18. Review.

2.

Possible link between hepatitis B infection and gastric cancer.

Lewis R.

Lancet Oncol. 2015 Apr;16(4):e159. doi: 10.1016/S1470-2045(15)70077-X. Epub 2015 Feb 27. No abstract available.

PMID:
25728524
3.

HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?

Vlachogiannakos J, Papatheodoridis GV.

Liver Int. 2014 Feb;34 Suppl 1:127-32. doi: 10.1111/liv.12404. Review.

PMID:
24373089
4.

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?

Vigan├▓ M, Mangia G, Lampertico P.

Liver Int. 2014 Feb;34 Suppl 1:120-6. doi: 10.1111/liv.12401. Review.

PMID:
24373088
5.

HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?

Kao JH.

Liver Int. 2014 Feb;34 Suppl 1:112-9. doi: 10.1111/liv.12400. Review.

PMID:
24373087
6.

HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?

Buti M.

Liver Int. 2014 Feb;34 Suppl 1:108-11. doi: 10.1111/liv.12392. Review.

PMID:
24373086
7.

Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.

Liu CJ.

J Gastroenterol Hepatol. 2014 Jan;29(1):26-30. doi: 10.1111/jgh.12421. Review.

PMID:
24199625
8.

Antiviral treatment for hepatitis B virus recurrence following liver transplantation.

Lee S, Kwon CH, Moon HH, Kim TS, Roh Y, Song S, Shin M, Kim JM, Park JB, Kim SJ, Joh JW, Lee SK.

Clin Transplant. 2013 Sep-Oct;27(5):E597-604. doi: 10.1111/ctr.12212.

PMID:
24093615
9.

Hepatitis B antivirals and resistance.

Devi U, Locarnini S.

Curr Opin Virol. 2013 Oct;3(5):495-500. doi: 10.1016/j.coviro.2013.08.006. Epub 2013 Sep 7. Review.

PMID:
24016777
10.

╬▓-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.

Hu Y, Cheng X, Cao F, Huang A, Tavis JE.

Antiviral Res. 2013 Sep;99(3):221-9. doi: 10.1016/j.antiviral.2013.06.007. Epub 2013 Jun 21.

PMID:
23796982
11.

Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.

Coppola N, Tonziello G, Colombatto P, Pisaturo M, Messina V, Moriconi F, Alessio L, Sagnelli C, Cavallone D, Brunetto M, Sagnelli E.

J Infect. 2013 Oct;67(4):322-8. doi: 10.1016/j.jinf.2013.06.006. Epub 2013 Jun 22.

PMID:
23796869
12.

Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.

McGonigal KH, Bajjoka IE, Abouljoud MS.

Pharmacotherapy. 2013 Sep;33(9):e170-6. doi: 10.1002/phar.1306. Epub 2013 Jun 6.

PMID:
23744810
13.

The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis.

Yu S, Jianqin H, Wei W, Jianrong H, Yida Y, Jifang S, Liang Y, Zhi C, Hongyu J.

Ann Hepatol. 2013 May-Jun;12(3):364-72. Review.

PMID:
23619252
14.

Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.

Wong DK, Seto WK, Fung J, Ip P, Huang FY, Lai CL, Yuen MF.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):1004-10.e1. doi: 10.1016/j.cgh.2013.01.026. Epub 2013 Feb 1.

PMID:
23376799
15.

Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.

Song ZL, Cui YJ, Zheng WP, Teng DH, Zheng H.

World J Gastroenterol. 2012 Dec 28;18(48):7149-57. doi: 10.3748/wjg.v18.i48.7149. Review.

16.

Small-molecule inhibitors for the treatment of hepatitis B virus documented in patents.

Geng CA, Wang LJ, Guo RH, Chen JJ.

Mini Rev Med Chem. 2013 Apr 1;13(5):749-76. Review.

PMID:
23317498
17.

Management of HBV in immunocompromised patients.

Pol S.

Liver Int. 2013 Feb;33 Suppl 1:182-7. doi: 10.1111/liv.12055. Review.

PMID:
23286863
18.

Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?

Papatheodoridis GV.

Liver Int. 2013 Feb;33 Suppl 1:151-6. doi: 10.1111/liv.12054. Review.

PMID:
23286859
19.

Impact of therapy on the outcome of chronic hepatitis B.

Liaw YF.

Liver Int. 2013 Feb;33 Suppl 1:111-5. doi: 10.1111/liv.12057. Review.

PMID:
23286854
20.

Rethinking therapeutic decisions for hepatitis B infection in Syria: insights into molecular monitoring.

Habbal W, Monem F.

J Infect Dev Ctries. 2012 Oct 19;6(10):744-7. doi: 10.3855/jidc.2596.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk